CompletedNot Applicable

Intra-articular Injection for the Relief of Temporomandibular Joint Pain

Egypt64 participantsStarted 2024-05-01

Plain-language summary

Which is more effective in the treatment of nonspecific temporomandibular osteoarthritis: platelet-rich plasma (PRP), hyaluronic acid, or triamcinolone acetonide?

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\. Patients with temporomandibular joint osteoarthritis with or without disc displacement. * 2\. Age ≥ 18 years \< 50 Exclusion Criteria: * 1\. Previous TMJ surgery * 2\. Medical history of blood-derived illness or any medication known to affect platelet function or concentration for a minimum of two weeks prior to treatment. * 3\. specific osteoarthritis like rheumatoid arthritis or psoriatic arthritis. * 4\. pregnant women or breastfeeding ones

What they're measuring

pain intensity

Timeframe: preoperative as baseline then after one week, 1 month, 3 months and 6 months

pain-free mouth opening

Timeframe: preoperative as baseline then after one week, 1 month, 3 months and 6 months

Trial details

NCT IDNCT07571265

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-25

View on ClinicalTrials.gov More Temporomandibular Arthritis trials